00:00It's like November 16, 2020, when we announced a phase 3 of COVID, a vaccine, you remember, we were on
00:06the show that morning.
00:08It's a big moment for medicine, a big moment for patients.
00:12We believe that this is just a first step for intismaran plus cathedra.
00:17We're excited what it's going to mean for patients.
00:20Already just hearing stories from patients in clinical studies has been really heartening.
00:25What's exciting about it is you're taking Keytruda, which many people know is a really important cancer drug that's approved
00:33in 20 different types of cancers.
00:36And if you add this personalized cancer treatment based on the technology of Moderna, and you treat patients with a
00:42really deadly disease, melanoma, you reduce that risk of recurrence, which essentially means that patients have a better chance of
00:50being disease-free and for longer.
Commenti